198 results
Page 5 of 10
8-K
EX-2.1
0snlpp1z dzp
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-99.2
0z831u98
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-99.1
osb62ht
24 Mar 22
Yumanity Therapeutics Reports Full-Year 2021 Financial Results and Recent Corporate Developments
4:21pm
8-K
EX-10.1
nzj2muryzcdegz
4 Mar 22
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-99.1
tfuqigghpksdd8
19 Jan 22
Yumanity Reports Partial Clinical Hold by U.S. FDA on Multidose Clinical Trials for YTX-7739
7:42am
8-K
EX-99.1
afhwo0ufhn8 l6xv
15 Nov 21
Yumanity Therapeutics Reports Third Quarter 2021 Financial Results and Recent Corporate Developments
7:42am
8-K
EX-99.2
jvye0a2e
10 Nov 21
Regulation FD Disclosure
7:12am
8-K
EX-99.1
jam kcu5csalvveeaiq2
10 Nov 21
Regulation FD Disclosure
7:12am
8-K
EX-99.1
ospu2oub
16 Aug 21
Yumanity Therapeutics Appoints Michael D. Wyzga as Chief Financial Officer and Announces Inducement Grants
7:21am
8-K
EX-99.1
svgu5j
12 Aug 21
Yumanity Therapeutics Reports Second Quarter 2021 Financial Results and Recent Corporate Developments
4:21pm
8-K
EX-99.1
7oikt2t 6b8
16 Jun 21
Regulation FD Disclosure
8:00am
8-K
EX-99.1
o29ckwc4ek3i404jy
17 May 21
Regulation FD Disclosure
5:03pm